CAS: 206269-27-4 - 1-(beta-L-Ribofuranosyl)-1H-1,2,4-triazole-3-carboxamide
Fórmula:C8H12N4O5
InChI:InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m0/s1
Clave InChI:InChIKey=IWUCXVSUMQZMFG-RGDLXGNYSA-N
SMILES:O=C(N)C=1N=CN(N1)C2OC(CO)C(O)C2O
- Sinónimos:
- 1-β-<span class="text-smallcaps">L</span>-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
- 1H-1,2,4-Triazole-3-carboxamide, 1-β-<span class="text-smallcaps">L</span>-ribofuranosyl-
- Icn-17261
- Levovirin
- R-1270
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Levovirin REF: TM-T25702CAS: 206269-27-4 | 100% - 99.96% | 272,00 €~2.562,00 € | Mar 10 Dic 24 |
 | Levovirin REF: TR-L379000CAS: 206269-27-4 | - - - | 300,00 €~1.954,00 € | Mar 21 Ene 25 |
 | Levovirin REF: 3D-IL167156CAS: 206269-27-4 | Min. 95% | A consultar | Mar 21 Ene 25 |
Levovirin
CAS:206269-27-4
Levovirin (L-Ribavirin) is a guanosine nucleoside analog that has immunomodulatory activity and is used in …
Fórmula:
C8H12N4O5
Pureza:
100% - 99.96%
Forma y color:
Solid
Peso molecular:
244.20
Ref: TM-T25702
| 1mg | 272,00 € | ||
| 2mg | 405,00 € | ||
| 5mg | 671,00 € | ||
| 10mg | 917,00 € | ||
| 25mg | 1.416,00 € | ||
| 50mg | 1.838,00 € | ||
| 100mg | 2.562,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
Levovirin
Producto controladoCAS:206269-27-4
Applications Levovirin is a monocyclic L-nucleosides with type 1 cytokine-inducing activity. Levovirin is the L-enantiomer …
Fórmula:
C8H12N4O5
Forma y color:
Neat
Peso molecular:
244.20
Ref: TR-L379000
| 10mg | 300,00 € | ||
| 100mg | 1.954,00 € |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
Levovirin
Producto controladoCAS:206269-27-4
Levovirin is an antiviral agent that belongs to the class of ribonucleotide reductase inhibitors. It …
Fórmula:
C8H12N4O5
Pureza:
Min. 95%
Peso molecular:
244.2 g/mol
Ref: 3D-IL167156
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
